Truist Financial Lowers UnitedHealth Group (NYSE:UNH) Price Target to $610.00

UnitedHealth Group (NYSE:UNH) had its price objective lowered by Truist Financial from $625.00 to $610.00 in a research note released on Monday morning, Marketbeat reports. The firm currently has a buy rating on the healthcare conglomerate’s stock.

A number of other research firms also recently weighed in on UNH. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Monday, December 9th. Stephens increased their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. TD Cowen increased their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Bank of America cut their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Finally, Cantor Fitzgerald raised their target price on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research note on Wednesday, October 16th. Three analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $627.58.

UnitedHealth Group Stock Up 1.9 %

UNH stock opened at $524.14 on Monday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The firm has a market capitalization of $482.36 billion, a PE ratio of 34.15, a P/E/G ratio of 1.53 and a beta of 0.62. The company’s 50 day simple moving average is $557.00 and its 200-day simple moving average is $561.46. UnitedHealth Group has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.56 earnings per share. Equities analysts expect that UnitedHealth Group will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in UNH. Chris Bulman Inc acquired a new position in UnitedHealth Group during the 2nd quarter worth $82,000. Acadian Asset Management LLC lifted its position in shares of UnitedHealth Group by 17.5% in the 2nd quarter. Acadian Asset Management LLC now owns 81,483 shares of the healthcare conglomerate’s stock worth $41,490,000 after buying an additional 12,145 shares during the last quarter. Stonekeep Investments LLC bought a new position in shares of UnitedHealth Group in the 2nd quarter worth about $436,000. Fairbanks Capital Management Inc. lifted its position in shares of UnitedHealth Group by 2.4% in the 2nd quarter. Fairbanks Capital Management Inc. now owns 7,061 shares of the healthcare conglomerate’s stock worth $3,596,000 after buying an additional 165 shares during the last quarter. Finally, HCR Wealth Advisors lifted its position in shares of UnitedHealth Group by 4.0% in the 2nd quarter. HCR Wealth Advisors now owns 2,204 shares of the healthcare conglomerate’s stock worth $1,122,000 after buying an additional 84 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.